Genetic Technologies Limited (ASX:GTG)
0.0390
0.00 (0.00%)
Oct 16, 2024, 1:07 PM AEST
Genetic Technologies Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 0.01 | 0.01 | 1.02 | 7.85 | 11.73 |
Short-Term Investments | - | - | - | 0.02 | 0.01 |
Cash & Short-Term Investments | 0.01 | 0.01 | 1.02 | 7.87 | 11.74 |
Cash Growth | 2.47% | -99.02% | -87.03% | -33.00% | -43.82% |
Accounts Receivable | 0.02 | - | 2.13 | 0.19 | 0.44 |
Other Receivables | - | - | - | 1.73 | 1.98 |
Receivables | 0.02 | - | 2.13 | 1.92 | 2.42 |
Inventory | - | - | 0.21 | 0.33 | 0.4 |
Prepaid Expenses | - | - | - | 0.38 | 0.15 |
Other Current Assets | 0.01 | - | 0.34 | - | 0 |
Total Current Assets | 0.04 | 0.01 | 3.7 | 10.5 | 14.72 |
Property, Plant & Equipment | - | - | 0.26 | 0.6 | 0.95 |
Goodwill | - | - | 1.78 | 3.12 | 4.51 |
Other Intangible Assets | - | - | 0.36 | 0.52 | 0.62 |
Long-Term Deferred Tax Assets | - | - | 0.08 | 0.12 | - |
Total Assets | 0.04 | 0.01 | 6.19 | 14.86 | 20.8 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.34 | - | 2.03 | 0.84 | 1.15 |
Accrued Expenses | - | - | - | 1.07 | 1.47 |
Short-Term Debt | 0.11 | - | 0.64 | - | - |
Current Portion of Leases | - | - | 0.21 | 0.3 | 0.26 |
Current Unearned Revenue | - | - | 0.74 | 0.85 | 0.81 |
Other Current Liabilities | - | - | 0.57 | 0.25 | 0.11 |
Total Current Liabilities | 0.46 | - | 4.2 | 3.31 | 3.81 |
Long-Term Leases | - | - | 0.02 | 0.23 | 0.39 |
Long-Term Deferred Tax Liabilities | - | - | 0.08 | 0.12 | 0.15 |
Other Long-Term Liabilities | - | - | 0.06 | 0.03 | 0.02 |
Total Liabilities | 0.46 | - | 4.36 | 3.69 | 4.37 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 164.33 | 164.33 | 163.82 | 161.34 | 155.14 |
Retained Earnings | -165.36 | -167.08 | -166.38 | -156.72 | -150.21 |
Comprehensive Income & Other | 0.61 | 2.76 | 4.39 | 6.54 | 11.5 |
Shareholders' Equity | -0.42 | 0.01 | 1.83 | 11.16 | 16.43 |
Total Liabilities & Equity | 0.04 | 0.01 | 6.19 | 14.86 | 20.8 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.11 | - | 0.88 | 0.53 | 0.65 |
Net Cash (Debt) | -0.1 | 0.01 | 0.15 | 7.34 | 11.09 |
Net Cash Growth | - | -93.12% | -98.02% | -33.86% | -46.41% |
Net Cash Per Share | -0.00 | 0.00 | 0.00 | 0.07 | 0.12 |
Filing Date Shares Outstanding | 1,658 | 1,335 | 145.42 | 115.42 | 92.34 |
Total Common Shares Outstanding | 1,658 | 1,335 | 132.22 | 115.42 | 92.34 |
Working Capital | -0.42 | 0.01 | -0.5 | 7.19 | 10.91 |
Book Value Per Share | -0.00 | 0.00 | 0.01 | 0.10 | 0.18 |
Tangible Book Value | -0.42 | 0.01 | -0.31 | 7.53 | 11.3 |
Tangible Book Value Per Share | -0.00 | 0.00 | -0.00 | 0.07 | 0.12 |
Machinery | - | - | - | 1.29 | 1.29 |